Chilblain lupus erythematosus associated with erdafitinib therapy in a patient with metastatic bladder cancer

By sjmartinez • December 10, 2024

Truong A, Liu J, Ni C, Yashar S. Chilblain lupus erythematosus associated with erdafitinib therapy in a patient with metastatic bladder cancer. JAAD Case Rep. 2024 Oct 28;54:62-65. doi: 10.1016/j.jdcr.2024.10.007. PMID: 39654848; PMCID: PMC11626054.

Tags: adverse reaction, chilblain lupus, cutaneous lupus, Dermatology, Drug reaction, erdafitinib, oncodermatology, Publications, Resident, side effect, targeted therapy, Veterans Administration

Related Posts

Lebrikizumab off-therapy remission sustained up to 38 weeks in atopic dermatitis

Silverberg JI, Bieber T, Eyerich K, Armstrong AW, Nickoloff BJ, Natalie CR, Gallo G, Okragly A, Wolf E, Xu C, Moser BA, Rueda MJ, Elmaraghy[...]

The liver regulates ectopic calcification in Abcc6-deficient models of Pseudoxanthoma Elasticum

Wang Y, Sun B, Ma F, Tao B, Gu Y, Zhou Z, Kim J, Zhang L, Liu Z, Ten Hoeve J, Stiles L, Fernandez-Del-Rio L,[...]

GLP-1RAs and cardiovascular risk reduction in psoriasis: A retrospective cohort study

Ma EJ, Roberts AM, Jeong CY, Chou P, Katz A, Nong Y, Johnsen N, Yan M, Ochoa MT, Armstrong AW. GLP-1RAs and cardiovascular risk reduction[...]